期刊文献+

维吾尔族男性急性冠状动脉综合征患者脂蛋白a、纤溶酶原激活抑制物-Ⅰ和纤维蛋白原水平变化及其相关性

Study of the levels and the correlation about lipoprotein(a), fibrinogen, plasminogen activator inhibitor-Ⅰ in uigur male patients with acute coronary syndromes
原文传递
导出
摘要 目的:观察维吾尔族男性急性冠状动脉综合征(ACS)患者血清脂蛋白(a)[LP(a)]、血浆纤溶酶原激活抑制物-Ⅰ(PAI-Ⅰ)及血浆纤维蛋白原(Fg)水平变化并分析其相关性。方法:维吾尔族男性119例,分为2组: ACS组66例,对照组53例;分别测定其血清LP(a)、血浆PAI-Ⅰ和血浆Fg水平。结果:ACS组、对照组血清LP (a)分别为(422.323±201.685)、(146.60±80.984)mmol/L;2组血浆PAI-Ⅰ含量吸收度(A值)分别为(1.276 ±0.831)和(0.369±0.418);血浆Fg水平分别是(4.688±0.970)、(3.515±0.507)g/L,2组间差异均有统计学意义(P<0.05)。将119例研究对象,按LP(a)分为≤300 mmol/L组和>300 mmol/L,比较2组PAI-Ⅰ含量和 Fg水平:LP(a)>300 mmol/L组(55例)A值为(1.182±0.842),Fg为(4.563±0.980)g/L;LP(a)≤300 mmol/ L组(64例),A值为(0.605±0.691),Fg为(3.824±0.864)g/L,经秩和检验2组间差异具有统计学意义(P< 0.01)。血清LP(a)与血浆PAI-Ⅰ含量相关分析,r=0.427,P<0.01;血清LP(a)与血浆Fg进行相关分析,r =0.441,P<0.01。结论:血清LP(a)、血浆PAI-Ⅰ和血浆Fg水平在维吾尔族男性ACS患者中明显增高;血清 LP(a)水平高者血浆PAI-Ⅰ及Fg亦有较高水平,血清LP(a)水平与血浆PAI-Ⅰ、Fg水平间呈正相关。维吾尔族男性LP(a)、PAI-Ⅰ和Fg水平增高与其冠心病临床事件的发生有关。 Objective: To investigate the changes and the correlation between lipoprotein(a)(LP[a]), plas minogen activator inhibitor- Ⅰ(PAI-Ⅰ) and fibrinogen(Fg) in uigur male patients with acute coronary syndromes (ACS). Method: The serum LP(a),absorb( A ) of the plasma plasminogn activator inhibitor-Ⅰ and the plasma Fibrinogen were detected in 119 uigur males. Sixy-six patients with acute coronary syndromes were enrolled as ACS group;the other 53 patiens without coronary heart disease(CHD) were enrolled as control group. Result: There were significant differences in serum LP(a), plasma PAI- Ⅰ , and Fg between the ACS group and the control group (LP(a) E422. 323±201. 685]mmol/L vs E146.60±80. 984]mmol/L; PAI-Ⅰ[1.275 8±0. 831 2]vs E0. 368 6±0. 417 8]; Fg[4. 6883±0. 969 7]g/L vs [3. 5145±0. 5068]g/L, P 〈0.05. The levels of PAI- Ⅰ in the subjects with LP(a)〉300mmol/L( n 55)were 1. 182 5±0. 841 7,and the levels of Fg in them were (4. 562 5±0. 979 7) g/L, while the levels of PAI- Ⅰ with LP(a) ≤300 retool/L( n =64) were 0. 6047 7 ±0. 6905 7,and their levels of Fg were (3. 824 4± 0. 864 0)g/L. There were significant differences between two groups . There is positive correlation between the levels of LP(a) and PAI- Ⅰ ( r =0. 427, P 〈0. 001) ,and between the levels of LP(a) and Fg ( r = 0. 441, P 〈0.01). Conclusion:The Uigur male patients with ACS had significantly increased levels of LP(a) ,PAF-Ⅰ ,Fg, and the subjects who had higher levels of LP(a) had higher levels of PAI-Ⅰ and Fg simultaneously. It proved that LP(a) ,PAI- Ⅰ and Fg may be risk factors of CHD in Uigur male patients.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2006年第5期282-284,共3页 Journal of Clinical Cardiology
关键词 急性冠状动脉综合征 维吾尔族 男性 脂蛋白A 纤溶酶原激活抑制物-Ⅰ 纤维蛋白原 Acute coronary syndromes Uigur male Lipoprotein(a) Plasminogen activator inhibitor- Ⅰ ;Fi brinogen
  • 相关文献

参考文献16

  • 1LUSIS A J. Atherosclerosis[J]. Nature, 2000,407:233-241. 被引量:1
  • 2PELTIER M, IANNETTA PELTIER M C, SARANO M E,et al. Elevated serum lipoprotein(a) level is an independent marker of severity of thoracic aortic atheroselerosis[J]. Chest, 2002,121:1589- 1594. 被引量:1
  • 3刘泽霖.动脉血栓形成与止血相关的遗传性危险因子(一)[J].血栓与止血学,2003,9(1):45-48. 被引量:3
  • 4DE LA PENA-DIAZ A, IZAGUIRRE AVILA R,ANGLES-CANO E. Lipoprotein (a) and athero-thrombotic disease[J]. Arch Med Res, 2000, 31: 353-359. 被引量:1
  • 5赵水平主编..临床血脂学[M].长沙:湖南科学技术出版社,1997:446.
  • 6孙芹敏,张丽霞.脂蛋白(a)与血栓性疾病[J].中国检验医学与临床,2000,1(2):79-80. 被引量:7
  • 7KOMAI N, MORISHITA R, YAMADA S, et al.Mitogenic activity ofoxidized lipoprotein(a) on human vascular smooth muscle cells [J] . Hypertension ,2002,40:310-314. 被引量:1
  • 8MOTTA M,GIUGNO I,, BOSCO S, et al . Serum lipoprotein(a) changes in acute myocardial infarction[J].Panminerva Med,2001 ,43:77-80. 被引量:1
  • 9DANESH J, COLLINS R, PETO R. Lipoprotein(a)and coronary heart disease meta-analysis of prospective studies[J]. Circulation, 2000,102:1082-1085. 被引量:1
  • 10ZAMPOULAKIS J D , KYRIAKOUSI A A, PORALIS K A et al. Lipoprotien(a) is related to the extent of lesions in coronary vasculature and to unstable coronary syndrom[J]. Clin Cardiol, 2000 , 23 : 895- 900. 被引量:1

二级参考文献14

  • 1[1]Scheuner M T. Genetic predisposition to coronary artery disease. Curr Opon Cardiol, 2001, 16:251-260. 被引量:1
  • 2[2]Danesh J,Collins R, Peto R. lipoprotern(a) and coronary heart disease. Meta-analysis of prospective studies.Circulation, 2000,102 : 1082- 1085. 被引量:1
  • 3[3]Li X N,Grenett H E,Benza R L,et al. Genotypespeciptional regulation of PAI-I expression by hypertridemeic LDL and Lp (a) in culture human endothelial cells. Arterioscler Thromb Vasc Biol, 1997,17:3215-3223. 被引量:1
  • 4[4]Angles-Cano E. Structual basis of the pathophysiology of lipoprotein(a) in the athero-thrombotic process. Braz J Med Biol Res,1997, 30:1271-1280. 被引量:1
  • 5[5]Chul K,Gerald T G,Thomas G A. Relation of high lipoprotein(a) to other traditional atherosclerotic risk factors in patients with coronary heart disease. Am J Cardiol, 2003,91 : 1360- 1363. 被引量:1
  • 6Luc G, Bard J M, Arveiler D, et al. Lipoprotein (a) as a predictor of coronary heart disease: The PRIME Study. Atherosclerosis, 2001,163(2):377-384. 被引量:1
  • 7Seman L G, Deluca C, Jenner J L,et al. Lipoprotein (a)-cholesterol and coronary heart disease in the Framingham Heart Study. Clin Chem, 1999,45(7):1039-1046. 被引量:1
  • 8Lundstam U, Herlitz J, Karlsson T, et al. Serum lipids, lipoprtein (a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease. J Intern Med, 2002,251(2):111-118. 被引量:1
  • 9Marcovina S M, Hegele R A, Koschinsky M L. Lipoprotein (a) and coronary heart disease risk. Curr Cardiol Rep,1999,1(2):105-111. 被引量:1
  • 10Angles C E. Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process. Braz J Med Biol Res,1997,30(11):1271-1280. 被引量:1

共引文献259

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部